PharmaShots | Incisive News in 3 Shots

Subscribe Now

two-Year

Schr'dinger Signs a Two-Year Research Collaboration with MD Anderson to Advance its WEE1 Program

Schr'dinger Signs a Two-Year Research Collaboration with MD Anderson to Advance its WEE1 Program

October 8, 2021

Roche Reports Two-Year Data for Evrysdi (risdiplam) in Infants with Type 1 SMA

Roche Reports Two-Year Data for Evrysdi (risdiplam) in Infants with Type 1 SMA

September 28, 2020

Sarepta Signs a Two-Year Research and Option Agreement with Codiak for Up to Five Neuromuscular Targets

Sarepta Signs a Two-Year Research and Option Agreement with Codiak for Up to Five Neuromuscular Targets

June 24, 2020

MSD Signs a Two-Year Research Agreement with Almac to Discover DUB Therapeutic Targets for Neurodegenerative Diseases

MSD Signs a Two-Year Research Agreement with Almac to Discover DUB Therapeutic Targets for Neurodegenerative Diseases

April 30, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us